Analyst Insights - Digital Health Posts

Read our Analysts’ insights and expert opinions on the latest healthcare technology industry developments and market trends. Signify Research provides both free insights and premium insights which are only available to subscribers of "Signify Premium Insights".
Click on the premium insights link below to filter for just the premium content.



Signify Premium Insight: FPDs and Pricing Pressures

Signify Premium Insights Subscription Required

16th February 2022 – Some of the key findings of Signify Research’s Medical Flat Panel Detector Supply – World – 2022 are identified by authors Bhvita Jani and Graham Cooke.

Signify Premium Insight: Medical Imaging AI’s Top Tier – The $100m Club

Signify Premium Insights Subscription Required

February 10th 2022 – There are only a handful of medical imaging AI vendors which have secured more than $100m in funding. While these companies are diverse in many ways, there are some attributes that have contributed to their success, which they share.

Signify Premium Insight: Clarius Claims Specialists in Tilt at Crowded Market

Signify Premium Insights Subscription Required

8th February 2022 – Clarius is targeting specialists with its new handheld ultrasound scanners, but is it enough to stand out in an increasingly crowded market?

Signify Premium Insight: RadNet is Full Screen Ahead with AI Acquisitions

Signify Premium Insights Subscription Required

February 3rd 2022 – With its acquisitions of Aidence and Quantib, RadNet has made clear its ambitions in cancer screening. But, as this Premium Insight highlights, there are several factors that will determine whether this play, as well as its plan to sell on its software, will be a success.

Huma Acquires iPLATO Healthcare – The Signify View

03rd February 2022 – Huma, a UK-based Remote Patient Monitoring (RPM) platform provider, recently announced its acquisition of iPLATO Healthcare, a major supplier of patient engagement software to primary care organisations throughout the UK. Here is the Signify View on this acquisition